1.Li C. F., Zhang W. G., Liu M., Qiu L. W., Chen X. F., Lv L., Mei Z. C. (梅浙川)(2016) Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression.Oncotarget.(消化内科)(IF: 6.359)

2.Xin Kong, Fengchao Liu, Jian Gao*(高建). MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways. Oncotarget, 2016; 7(40): 66051-66060.(IF:6.359)

3.Gao W., Zheng Y.(郑元义), Wang R., Chen H., Cai X., Lu G., Chu L., Xu C., Zhang N., Wang Z., Ran H., Li P., Yang C., Mei Z.(梅浙川), Song J.(*) (2016) A smart, phase transitional and injectable DOX/PLGA-Fe implant for magnetic-hyperthermia-induced synergistic tumor eradication. Acta Biomater 29: 298-306.(超研所)(IF: 6.025)

4.Zhang W. G., Li C. F., Liu M., Chen X. F., Shuai K., Kong X., Lv L., Mei Z. C.(梅浙川) (2016) Aquaporin 9 is down-regulated in hepatocellular carcinoma and its over-expression suppresses hepatoma cell invasion through inhibiting epithelial-to-mesenchymal transition. Cancer Lett 378: 111-119.(消化内科)(IF: 5.621)

5.Zeng J., Lv L., Mei Z. C.(梅浙川) (2016) Budesonide foam for mild to moderate distal ulcerative colitis: a systematic review and meta-analysis. J Gastroenterol Hepatol.(消化内科)(IF: 3.504)

6.Wang Y., Deng T., Zeng L., Chen W. (陈伟庆)(2016) Efficacy and safety of radiofrequency ablation and transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: A meta-analysis. Hepatol Res 46: 58-71.(消化内科)(IF: 2.735)

7.Tang A., Li C., Zou N., Zhang Q., Liu M., Zhang X.(张霞) (2016) Angiotensin-(1-7) improves non-alcoholic steatohepatitis via an adiponectin-independent mechanism. Hepatol Res.(消化内科)(IF: 2.735)

8.Fan JH, Xiang MQ, Li QL, Shi HT, Guo JJ*(郭进军). PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis. Gut Liver. 2016 May 23;10(3):456-63. doi: 10.5009/gnl15261.(通讯作者)(IF:2.0)

9.Fan JH, Hou SH, Qing-Ling L, Hu J, Peng H, Guo JJ*(郭进军). Association of HLA-DQ and IFNL4 polymorphisms with susceptibility to hepatitis B virus infection and clearance. Ann Hepatol. 2016 Jul-Aug;15(4):532-9. (通讯作者)(SCI=1.816)

10.Han R., Lu H., Jiang M. W., Tan K. W., Peng Z., Hu J. L., Fang D. C., Lan C. H.(*), Wu X. L(吴小翎). (2016) Multicenter Study of Antibiotic Resistance Profile of H. pylori and Distribution of CYP2C19 Gene Polymorphism in Rural Population of Chongqing, China. Gastroenterol Res Pract 2016: 8547686.(消化内科)(IF: 1.749)

11.Zeng J., Lv L., Mei Z. C.(梅浙川) (2016) Efficacy and safety of transarterial chemoembolization plus sorafenib for early or intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials. Clin Res Hepatol Gastroenterol.(消化内科)(IF: 1.638)

12.Lu L., Liu T., Gao J., Zeng H., Chen J., Gu X., Mei Z.(梅浙川) (2016) Aberrant methylation of microRNA-193b in human Barrett's esophagus and esophageal adenocarcinoma. Mol Med Rep 14: 283-288.(消化内科)(IF: 1.554)

13.Chen X. F., Li C. F., Lu L., Mei Z. C.(梅浙川) (2016) Expression and clinical significance of aquaglyceroporins in human hepatocellular carcinoma. Mol Med Rep 13: 5283-5289.(消化内科)(IF: 1.554)

14.Zeng J., Lv L., Mei Z. C.(梅浙川) (2017) Budesonide foam for mild to moderate distal ulcerative colitis: A systematic review and meta-analysis. J Gastroenterol Hepatol 32: 558-566.(IF: 3.322)

15.Du X., Cai C., Yao J., Zhou Y., Yu H., Shen W.(沈薇) (2017) Histone modifications in FASN modulated by sterol regulatory element-binding protein 1c and carbohydrate responsive-element binding protein under insulin stimulation are related to NAFLD. Biochem Biophys Res Commun 483: 409-417.(IF: 2.371)

16.Liu Y., Zhang W., Wu X.(吴小翎), Gong J. (2017) Foxo3a-dependent Bim transcription protects mice from a high fat diet via inhibition of activation of the NLRP3 inflammasome by facilitating autophagy flux in Kupffer cells. Oncotarget 8: 34258-34267.(IF: 5.008)

17.Bo Ning(宁波),Mohamed M.Abdelfatah,Mohamed O.Othman(2017)Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer.Annals of Cardiothoracic Surgery 6: 88-98.(IF: 1.73)

18.Yu Liming,He Song(何松). The C-terminus domain of the hepatitis B virus X protein stimulates the proliferation of mouse foetal hepatic progenitor cells, although it is not required for the formation of spheroids. International Journal of Molecular Medicine, 2017,40(2):400-410 (IF:2.348)

19.Li X., Jiang T., Gao J.(高建) (2017) Endoscopic variceal ligation combined with argon plasma coagulation versus ligation alone for the secondary prophylaxis of variceal bleeding: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 29: 621-628.(IF: 1.968)

20.Tingting Jiang, Xiaoping Luo, Jianming Sun, Jian Gao*(高建). Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World J Gastroenterol 2017; 23(41): 7470-7477.(IF: 3.365)

21. Cai C.(蔡璨), Zhu X., Li P., Li J., Gong J., Shen W.(沈薇), He K.(2017)  NLRP3  Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic  Acid. Inflammation 40: 1875-1883.(IF: 2.618)

22.Zhang W., Liu Y., Wu M., Zhu X., Wang T., He K., Li P., Wu X.(吴小翎) (2017) PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells. J Physiol Biochem 73: 583-594.(IF: 2.054)

23.Zhao H.(赵红雲), Wu M., Zhu L., Tian Y., Wu M., Li Y., Deng L., Jiang W., Shen

W., Wang Z., Mei Z., Li P., Ran H., Zhou Z.(周志益), Ren J.(任建丽) (2018) Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma. Theranostics 8: 1892-1910.(IF: 8.766)

24.Liu F., Wu X.(吴小翎), Jiang X., Qian Y., Gao J.(高建) (2018) Prolonged

inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3beta/beta-catenin signalling. J Exp Clin Cancer Res 37: 122.(IF: 6.217)

25.Qiu C., Liu Y., Mei Y., Zou M., Zhao Z., Ye M.(*), Wu X.(吴小翎) (2018)

Ubiquitin-specific protease 4 promotes metastasis of hepatocellular carcinoma by increasing TGF-beta signaling-induced epithelial-mesenchymal transition. Aging (Albany NY) 10: 2783-2799.(IF: 5.179)

26.Zhou Y., Yu S., Cai C., Zhong L., Yu H.(俞慧宏), Shen W.(沈薇) (2018) LXRa

participates in the mTOR/S6K1/SREBP-1c signaling pathway during sodium palmitate-induced lipogenesis in HepG2 cells. Nutr Metab (Lond) 15: 31.(IF: 3.48)

27.Liao S., Gan L., Qin W., Liu C., Mei Z.(梅浙川) (2018) Inhibition of GSK3 and

MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways. Oncol Rep 40: 2005-2013.(IF: 2.976)

28.Cai C.(蔡璨), Yu H., Huang G., Du X., Yu X., Zhou Y., Shen W. (沈薇)(2018)

Histone modifications in fatty acid synthase modulated by carbohydrate responsive element binding protein are associated with nonalcoholic fatty liver disease. Int J Mol Med 42: 1215-1228.(IF: 2.784)

29.Zhu J., Cao J. F., Zhang T., Li T. Y., Li X. W., Shen W.(沈薇) (2018) Multilocus

sequence typing for Candida albicans strains from the intestinal tract of patients with cirrhosis. Eur Rev Med Pharmacol Sci 22: 6063-6071.(IF: 2.378)

30.Yuxue Hu, Xiaoyan Li, Jian Gao*(高建). Correlation among the expression of

CD133, CD90, and poor survival outcome in hepatocellular carcinoma: a meta-analysis. Int J Clin Exp Med, 2018; 11(4): 2965-2977. (IF: 1.069)

31.Xin Jiang, Fengchao Liu, Yiying Wang, Jian Gao*.(高建) Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes. J Gastroenterol Hepatol, 2019; Apr 30, 1-9.doi:10.1111/jgh.14692.(IF:3.632)

32.Xiaopeng Hu, Jian Gao*.(高建) International normalized ratio and Model for End-stage Liver Disease score predict short-term outcome in cirrhotic patients after the resolution of hepatic encephalopathy. World J Gastroenterol, 2019;25(26):3426-3437. (IF:3.411)

33.Pan, C; Liu, Q; Wu, XL*.(吴小翎)HIF1 alpha/miR-520a-3p/AKT1/mTOR Feedback Promotes The Proliferation And Glycolysis Of Gastric Cancer Cells. CANCER MANAGEMENT AND RESEARCH.2019.11.10145-10156.(IF:2.243)

34.Li Z., Rong L., Lian H., Cheng J., Wu X.(吴小翎), Li X.(*) (2019) Knockdown MTMR14 promotes cell apoptosis and inhibits migration in liver cancer cells. Gene 691: 106-113.(IF: 2.415)

35.Shi X, Luo H, Ning B.(宁波)Effect of cap-assisted esophagogastroduodenoscopy on examination of the major duodenal papilla: a noninferior, randomized controlled trial.

Endoscopy. 2019 May;51(5):427-435. (IF:5.21)

36.Li Jun-Chen, Hao Zhang.(张浩)Loss of the Tumor Suppressor HACE1 Contributes

to Cancer Progression. Current drug targets. 2019;20(10):1018-1028. (IF:3.236)

37. Zhou Z. H., Wang Q. L., Mao L. H., Li X. Q., Liu P., Song J. W., Liu X., Xu F., Lei J., He S.(何松)Chromatin accessibility changes are associated with enhanced growth and liver metastasis capacity of acid-adapted colorectal cancer cells. Cell Cycle 18: 511-522.(IF: 3.304)

38. Yu Y., Min Z., Zhou Zhihang, Linhong M., Tao R., Yan L., Song H.(何松)Hypoxia-induced exosomes promote hepatocellular carcinoma proliferation and metastasis via miR-1273f transfer. Exp Cell Res 385: 111649.(IF: 3.329)

39.Wu K,Song Q,Gou Y,He S.(何松)Sandwich method with or without lauromacrogol in the treatment of gastric variceal bleeding with liver cirrhosis : A meta-analysis. Medicine,2019,98(26):e16201(IF:1.87)

40.Li Xiaoqin,Lei Jing,Zhou ZH,He S.NAMPT and NAPRT,key enzymes in DAN salvage synthesis pathway,are of negative prognostic value in colorectal cancer.Frontiers in Oncology,2019;AUG6.(IF:4.137)

41.Chuanfei Li(李传飞), Feng Qin, Hao Hong, Hui Tang,Xiaoling Jiang,Shuangyan Yang,Zhechuan Mei(梅浙川), Di Zhou. "Identification of Flap endonuclease 1 as a potential core gene in hepatocellular carcinoma by integrated bioinformatics analysis." PeerJ 7: e7619. (IF:2.353)

42.Shengtao Liao,Li Gan, Zhechuan Mei.(梅浙川)Does the use of proton pump inhibitors increase the risk of hypomagnesemia An updated systematic review and meta-analysis.Medicine,2019.(IF:1.87)